Please login to the form below

Not currently logged in
Email:
Password:

disease management

This page shows the latest disease management news and features for those working in and with pharma, biotech and healthcare.

Novartis gets breakthrough tag from FDA for sickle cell drug

Novartis gets breakthrough tag from FDA for sickle cell drug

Latest pipeline therapy for painful blood disorder. A monthly antibody drug to treat sickle cell disease, developed by Novartis, has won a coveted breakthrough designation from the FDA as it heads ... Crizanlizumab is just one of a series of new dugs

Latest news

  • D-day: time to make digital deliver D-day: time to make digital deliver

    while clinical decision support systems and medicines adherence tools are supporting health stakeholders in the management of disease. ... However, if the development of digital tools is to benefit from the undoubted expertise that pharma can bring to

  • Google boosts healthcare business with new hire Google boosts healthcare business with new hire

    disease management. ... care to enable ‘simple and intelligence disease management’.

  • Celgene to launch five new products through to 2020 Celgene to launch five new products through to 2020

    registration trial in this indication – TRUE NORTH – as well as studies in Crohn’s disease. ... Celgene's fundamentals are strong, including robust commercial performance, a broad transformative pipeline, and a strengthened management team,” said

  • Safety first: AI adoption in the healthcare sector Safety first: AI adoption in the healthcare sector

    For example:. Smartphone apps encourage individuals with the proactive management of a healthy lifestyle. ... AI helps clinicians take a more comprehensive approach for disease management and better coordinate care plans.

  • Novo Nordisk to launch connected insulin pens Novo Nordisk to launch connected insulin pens

    In addition to demand from patients, healthcare payers, especially in the US, are calling for comprehensive disease management platforms. ... Global Head of Roche Diabetes Care Marcel Gmuender added that, "synching Novo Nordisk insulin data with our

More from news
Approximately 4 fully matching, plus 168 partially matching documents found.

Latest Intelligence

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Prof Craig Ritchie. “EPAD is part of a global initiative that will make a fundamental difference to the understanding and management of Alzheimer’s disease in people with very early symptoms, ... Diseases include Alzheimer’s, dementia with Lewy

  • Rare Diseases Day Rare Diseases Day

    On Rare Disease Day in 2019 it is surprising to note that few rare diseases have benefited from the digitisation of condition management and disease information in the same way as ... One in 20 people will be affected by a rare disease at some point in

  • Diagnosed Anywhere Diagnosed Anywhere

    Those distributed healthcare destinations will be powered by new diagnostic tools that help pharmacists act like disease detectives, not just dispensers and injectors. ... They already offer vision and audiology services, active chronic disease care and

  • Behaviour change: what is the buzz all about? Behaviour change: what is the buzz all about?

    Patients have always been a stakeholder in healthcare, but often a ‘sleeping partner’ – the individual with the disease that the healthcare professional would manage. ... Furthermore, it is the patient who ultimately determines if a medication is

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    AstraZeneca’s goal is to realise complete disease management, covering prevention, screening, diagnosis, treatment and follow- up. ... Earlier this year, it unveiled new partnerships with tech giants Alibaba and Tencent to increase the accessibility of

More from intelligence
Approximately 0 fully matching, plus 46 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”. ... Atkins said: “Britten joins our Senior Management team at a

  • Hugh Cole joins Jounce Therapeutics as chief business officer Hugh Cole joins Jounce Therapeutics as chief business officer

    Cole brings over 25 years’ experience in biotech including business development, corporate strategy, R&D, alliance management, commercial planning and execution and corporate leadership. ... He has also held roles for Oscient Pharmaceuticals, The

  • Glyconics appoints CEO Glyconics appoints CEO

    Dr Kam Pooni joins the UK diagnostics firm. UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 26 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics